Methods and apparatus for extracting doxorubicin from blood and measuring doxorubicin in blood

US11071812B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11071812-B2
Application numberUS-201715608023-A
CountryUS
Kind codeB2
Filing dateMay 30, 2017
Priority dateMay 31, 2016
Publication dateJul 27, 2021
Grant dateJul 27, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Doxorubicin is extracted from blood using anionic material, such as a resin comprising sulfonated polystyrene divinylbenzene beads, and polyethersulfone membrane, or both. After exposing the resin and/or membrane to blood in order to remove doxorubicin therefrom, the doxorubicin maybe extracted from the resin and/or membrane by exposing the material to an extraction solution, sonicating the extraction solution to enhance release of the doxorubicin, and repeating the exposure and sonication in order to remove substantially all of doxorubicin from the resin.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for measuring doxorubicin present in a patient's blood, said method comprising: mixing a sample of the patient's blood with a silver nitrate solution; adding a volume of methanol to the mixture; further mixing the blood, silver nitrate, and methanol together for at least 10 seconds; letting the mixed blood, silver nitrate, and methanol stand for at least 30 minutes to precipitate particles and form a supernatant; separating the supernatant via chromatography, wherein the separated supernatant contains doxorubicin originally present in the blood sample; and analyzing the separated supernatant via spectroscopy, wherein the UV absorbance of doxorubicin is measured. 2. The method of claim 1 , including the step of analyzing the separated supernatant via spectroscopy at 254 nm. 3. The method of claim 1 , including the step of analyzing the separated supernatant via spectroscopy at 480 nm. 4. The method of claim 1 , wherein a chromatography buffer comprises acetonitrile and NaH 2 PO 4 . 5. The method of claim 1 , wherein the total mixed volume of the sample of the patient's blood with the silver nitrate solution is below 200 μl. 6. The method of claim 1 , wherein the volume of methanol added to the mixture is less than or equal to 1 ml.

Assignees

Inventors

Classifications

  • Cation exchangers for chromatographic processes · CPC title

  • by absorption (A61M1/3675 takes precedence) · CPC title

  • Processes using organic exchangers · CPC title

  • A61M1/3615Primary

    Cleaning blood contaminated by local chemotherapy of a body part temporarily isolated from the blood circuit · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11071812B2 cover?
Doxorubicin is extracted from blood using anionic material, such as a resin comprising sulfonated polystyrene divinylbenzene beads, and polyethersulfone membrane, or both. After exposing the resin and/or membrane to blood in order to remove doxorubicin therefrom, the doxorubicin maybe extracted from the resin and/or membrane by exposing the material to an extraction solution, sonicating the ext…
Who is the assignee on this patent?
Penumbra Inc
What technology area does this patent fall under?
Primary CPC classification A61M1/3615. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).